2YGQ
WIF domain-epidermal growth factor (EGF)-like domains 1-3 of human Wnt inhibitory factor 1 in complex with 1,2- dipalmitoylphosphatidylcholine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I03 |
Synchrotron site | Diamond |
Beamline | I03 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | ADSC CCD |
Spacegroup name | I 21 3 |
Unit cell lengths | 178.007, 178.007, 178.007 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 39.804 - 3.951 |
R-factor | 0.2985 |
Rwork | 0.297 |
R-free | 0.33060 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.014 |
RMSD bond angle | 2.087 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | PHENIX ((PHENIX.REFINE: 1.7_650)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 4.090 |
High resolution limit [Å] | 3.950 | 3.950 |
Rmerge | 0.100 | 0.870 |
Number of reflections | 8403 | |
<I/σ(I)> | 27.2 | 2.8 |
Completeness [%] | 99.9 | 99.8 |
Redundancy | 11.1 | 10.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 5.7 | 0.75 M SODIUM SUCCINATE PH 5.7, 35 MG/ML SUCROSE OCTASULFATE |